Emtricitabine And Tenofovir Disoproxil Fumarate
Product Images NDC 67296-1830

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 67296-1830). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (D87907c8 88f3 4bdf Bdc4 3f8e4968f33c 01)

Image (D87907c8 88f3 4bdf Bdc4 3f8e4968f33c 01)
Chemical structure of emtricitabine, an active ingredient in Emtricitabine and tenofovir disoproxil fumarate. The diagram shows the molecular layout with atoms and bonds, highlighting functional groups including hydroxyl, amine, and fluorine substitutions.*
FDA Label Image

Image (D87907c8 88f3 4bdf Bdc4 3f8e4968f33c 02)

Image (D87907c8 88f3 4bdf Bdc4 3f8e4968f33c 02)
Chemical structure of the active ingredients emtricitabine and tenofovir disoproxil fumarate, showing molecular bonds and functional groups.*
FDA Label Image

Image (D87907c8 88f3 4bdf Bdc4 3f8e4968f33c 03)

Image (D87907c8 88f3 4bdf Bdc4 3f8e4968f33c 03)
Label for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets 100 mg/150 mg by Redpharm Drug, Inc. The label includes the NDC number 70710-1364-3, pack size of 30 tablets, and the distributor is Zydus Pharmaceuticals (USA) Inc. Storage instructions, dosage directions, and a child-resistant package warning are also present.*
FDA Label Image

Image (D87907c8 88f3 4bdf Bdc4 3f8e4968f33c 04)

Image (D87907c8 88f3 4bdf Bdc4 3f8e4968f33c 04)
Label for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 133 mg/200 mg strength, from Zydus Pharmaceuticals. The label indicates a 30 tablet package, Rx only, with storage instructions and dispensing warnings. It includes manufacturer and distributor information: Cadila Healthcare Ltd., India, and Zydus Pharmaceuticals (USA) Inc., NJ.*
FDA Label Image

Image (D87907c8 88f3 4bdf Bdc4 3f8e4968f33c 05)

Image (D87907c8 88f3 4bdf Bdc4 3f8e4968f33c 05)
Label for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets 167 mg/250 mg by Zydus Pharmaceuticals. The label includes NDC 70710-1366-3, pharmaceutical instructions for pharmacists, storage instructions, tablet count of 30, and distribution and manufacturing information. The label design features red, white, and purple colors with dosage strength highlighted in a red box.*
FDA Label Image

Image (D87907c8 88f3 4bdf Bdc4 3f8e4968f33c 06)

Image (D87907c8 88f3 4bdf Bdc4 3f8e4968f33c 06)
Label for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 200 mg/300 mg, showing a package of 30 film-coated tablets. The label includes dosage strength, NDC 70710-1367-3, instructions for pharmacists, storage conditions, child-resistant packaging notice, manufacturing by Cadila Healthcare Ltd., India, and distribution by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ. The label also features a barcode and Zydus Pharmaceuticals branding.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.